UK's medtech firm Oxford Cancer Analytics bags 10.6MOXcan has raised $11M for developing next-gen blood tests aimed at early lung cancer detection.Dr. Heinrich Roder has been appointed SVP of Research & Development, bringing extensive expertise in cancer diagnostics.
Dennis Lo, molecular biologist: There is an exchange of genetic information between the baby and the mother'Blood circulation exchange between mother and baby is much more intimate than previously thought, allowing for noninvasive prenatal diagnosis.
Predictive blood test hailed as incredibly exciting' breast cancer breakthroughA new blood test can predict breast cancer recurrence years in advance, aiding early treatment and potentially improved survival rates.